Our results indicated that PERK knockdown causes increased cell viability and decreased LDH cytotoxicity compared with control (CTL) knockdown in PPZ023-treated NSCLC cells (Fig. 4a, b). This evidence concerns the gene EIF2AK3 and non-small cell lung carcinoma.